NCT06427226 2026-04-17
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Tanta University
Phase 2 Recruiting
Clinical Trials
6 trialsNCT07245069 2025-11-24
Alpaca
University Medical Centre Ljubljana
Phase 2 Recruiting
NCT06491680 2025-09-22
Cardiotoxicity in Breast Cancer Patients
Helwan University
Phase 4 Recruiting
NCT05989347 2025-03-19
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy
Yale University
Phase 1 Recruiting
NCT06304857 2024-12-04
PROTECTAA
4th Military Clinical Hospital with Polyclinic, Poland
Phase 3 Recruiting
NCT06711185 2024-12-02
DAPA-MYOCANCER
University of Campinas, Brazil
Phase 3 Recruiting